Vaccines in Multiple Sclerosis. - Wikidata - awgldk - TriplyDB

Vaccines in Multiple Sclerosis.

Vaccines in Multiple Sclerosis.

http://www.wikidata.org/entity/Q38752982

about

Frequently asked questions on seven rare adverse events following immunization.Immune response to vaccines is maintained in patients treated with dimethyl fumarate.Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy.

P2860

Q30234430-95EDBC52-6CA9-4107-A562-07DEEE9D770D Q47093713-8A0FDE7D-9860-4981-B787-EA0525725D19 Q47569520-94FBA4AE-BDFF-403F-9D38-318113E5B859

P2860

Vaccines in Multiple Sclerosis.

http://www.wikidata.org/entity/Q38752982

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Vaccines in Multiple Sclerosis.

@en

type

label

Vaccines in Multiple Sclerosis.

@en

prefLabel

Vaccines in Multiple Sclerosis.

@en

P1433

Q38752982-BEFFC7FF-9E7F-4EEF-ABB4-2BAACA65C320

P1476

Q38752982-BE07502F-6461-4EDE-8BB5-D625DDC3FB34

P2093

Q38752982-10101212-8B41-417C-B17D-6464BAEEF045

Q38752982-77474F05-07C8-494D-ACF5-EAD740A87E90

Q38752982-BE2F38A2-4EAF-4FD0-A4C0-8B65103EDB84

P2860

Q38752982-0220E2C1-34A5-4F8A-A24B-B99931F7E3F6

Q38752982-1A2421DC-DF6D-4832-9ACB-9165A563CC74

Q38752982-1DE4913A-1C36-42A1-A916-8012999311C0

Q38752982-2F739410-7A4E-4932-8D50-989FD38414AE

Q38752982-303768A9-14B0-466B-9207-A25826839876

Q38752982-3317536F-BFE5-48F7-A4AE-DBDF2717E9A4

Q38752982-36FA5803-200A-475C-916B-F886332D2494

Q38752982-3B40F050-968C-4F0F-B50B-BB71B53EA5A1

Q38752982-3DA3D5F4-C0FA-493A-A874-B2FD0BEC591F

Q38752982-4E146FB1-39EB-4ECD-9700-77979C79D7BA

P2888

Q38752982-5FE7E333-3FD9-49CB-8D47-26F5E3946EFB

P304

Q38752982-A2CE5B88-9510-4138-9DEC-6C10B324B7AD

P31

Q38752982-E7C27C01-2E68-4149-9944-A1B3FC46C87F

P356

Q38752982-7CA280D3-89A0-400E-A02C-BFF0F520A872

P433

Q38752982-C3C28807-F954-46B2-A106-6CDBCEE0A407

P478

Q38752982-0C1033F7-A53A-4908-9D99-0FE0BE2E979D

P577

Q38752982-B2B97903-6E48-42EA-8AAE-D55EF303FCD3

P6179

Q38752982-4F0A4B74-ED8F-4CA1-9CB6-6A52A1699A7B

P698

Q38752982-FECAA0DF-6E60-4875-ADC9-278BC28D3578

P356

S11910-016-0637-6

P1433

Current Neurology and Neuroscience Reports

P1476

Vaccines in Multiple Sclerosis.

@en

P2093

Eric M L Williamson

http://www.w3.org/2001/XMLSchema#string

Joseph R Berger

http://www.w3.org/2001/XMLSchema#string

Salim Chahin

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.

Immunization and MS: a summary of published evidence and recommendations.

Infection risk in patients on multiple sclerosis therapeutics.

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.

Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.

Vaccinations and risk of central nervous system demyelinating diseases in adults.

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group.

Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy.

Tetanus vaccination and risk of multiple sclerosis: a systematic review.

P2888

s11910-016-0637-6

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-016-0637-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012829175

http://www.w3.org/2001/XMLSchema#string

P698

26922172

http://www.w3.org/2001/XMLSchema#string